| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Log 1/D50 | = | 5.09 |
| Log 1/D50 | = | 4.37 |
| Log 1/D50 | = | 5.58 |
| Log 1/D50 | = | 4.27 |
| Log 1/D50 | = | 5.04 |
| Log 1/D50 | < | 3 |
| Log 1/D50 | = | 4.39 |
| Log 1/D50 | < | 3 |
| Log 1/D50 | < | 3.37 |
| Log 1/D50 | = | 4.77 |
| Log 1/D50 | = | 3.61 |
| Log 1/D50 | = | 4.9 |
| Log 1/D50 | = | 4.35 |
| Log 1/D50 | < | 3.31 |
| Log 1/D50 | = | 4.94 |
| Log 1/D50 | = | 5.24 |
| Log 1/D50 | = | 5.09 |
| Log 1/D50 | = | 5.15 |
| Log 1/D50 | = | 3.76 |
| Log 1/D50 | = | 4.14 |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Ratio | = | 1.022 |
| Ratio | = | 1.015 |
| Ratio | = | 1 |
| Ratio | = | 0.6667 |
| Ratio | = | 0.8734 |
| Ratio | = | 0.8 |
| Ratio | = | 0.7564 |
| Ratio | = | 1.105 |
| Ratio | = | 0.8889 |
| Ratio | = | 1 |
| Ratio | = | 0.7253 |
| Ratio | = | 1.104 |
| Ratio | = | 0.8919 |
| Ratio | = | 1.5 |
| Ratio | = | 1.066 |
| Ratio | = | 1.052 |
| Ratio | = | 1.02 |
| Ratio | = | 1.032 |
| Ratio | = | 0.6522 |
| Ratio | = | 0.9841 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| Schizont size | = | 39.14 | um | 62.50 pixels | |
| 0.0381 | IC50 | = | 38.1 | nM | |
| Schizont size | = | 69.2 | um | 110.50 pixels | |
| 0.01152 | IC50 | = | 11.52 | nM | |
| Schizont size | = | 24.32 | um | 38.83 pixels | |
| 0.0491 | IC50 | = | 49.1 | nM | |
| Schizont size | = | 13.88 | um | 22.17 pixels | |
| 10 | IC50 | > | 10000 | nM | |
| Schizont size | = | 246.12 | um | 393.00 pixels | |
| 0.0911 | IC50 | = | 91.1 | nM | |
| Schizont size | = | 61.06 | um | 97.50 pixels | |
| 0.058 | IC50 | = | 58 | nM | |
| Schizont size | = | 90.91 | um | 145.17 pixels | |
| 10 | IC50 | > | 10000 | nM | |
| Schizont size | = | 17.54 | um | 28.00 pixels | |
| 0.0045 | IC50 | = | 4.5 | nM | |
| Schizont size | = | 37.89 | um | 60.50 pixels | |
| 0.433 | IC50 | = | 433 | nM | |
| Schizont size | = | 27.24 | um | 43.50 pixels | |
| Schizont size | Not Determined |
| Standard Type | Activity Comment |
|---|---|
| Activity | Inactive |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Active |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Active |
| Activity | Inactive |
| Activity | Active |
| Activity | Active |
| Activity | Active |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Inactive |
| Activity | Active |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| Inhibition | = | 79.74 | % | |
| Inhibition | = | -2.54 | % | |
| Inhibition | = | -4.075 | % | |
| Inhibition | = | 73.84 | % | |
| Inhibition | = | -45.62 | % | Outside typical range |
| Inhibition | = | 7.066 | % | |
| Inhibition | = | 55.64 | % | |
| Inhibition | = | -19.28 | % | Outside typical range |
| Inhibition | = | -13.35 | % | Outside typical range |
| Inhibition | = | -16.47 | % | Outside typical range |
| Inhibition | = | -55.29 | % | Outside typical range |
| Inhibition | = | -51.26 | % | Outside typical range |
| Inhibition | = | -10.13 | % | Outside typical range |
| Inhibition | = | 27.1 | % | |
| Inhibition | = | 4.698 | % | |
| Inhibition | = | -4.73 | % | |
| Inhibition | = | -5.937 | % | |
| Inhibition | = | -4.981 | % | |
| Inhibition | = | 41.18 | % | |
| Inhibition | = | 13.55 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Motility | = | 100 | % | Activity score: 0.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 66.6 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| Motility | = | 100 | % | Activity score: 1.0 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.079 | IC50 | = | 79 | nM |
| 0.021 | IC50 | = | 21 | nM |
| 10 | IC50 | > | 10000 | nM |
| 0.22 | IC50 | = | 220 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000040000 uM | Activity at 0.0000163452 uM | Activity at 0.0000320000 uM | Activity at 0.0000806082 uM | Activity at 0.0001439601 uM | Activity at 0.0003895389 uM | Activity at 0.0007288991 uM | Activity at 0.00154 uM | Activity at 0.00290 uM | Activity at 0.00454 uM | Activity at 0.00833 uM | Activity at 0.021 uM | Activity at 0.041 uM | Activity at 0.095 uM | Activity at 0.199 uM | Activity at 0.321 uM | Activity at 0.689 uM | Activity at 1.028 uM | Activity at 2.684 uM | Activity at 5.101 uM | Activity at 10.05 uM | Activity at 24.85 uM | Activity at 39.21 uM | Activity at 78.39 uM | Activity at 125.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 58.4116 | 43.5916 | 25.8843 | 33.4207 | 9.1109 | 21.6395 | 45.6886 | 10.8911 | 28.3955 | 31.3127 | 38.9914 | 41.6558 | 58.4116 | QC'd by Sytravon | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -12.6805 | -10.7548 | -9.5107 | -10.6418 | -15.9997 | -12.6805 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.1462 | -9.2235 | -11.8601 | -6.118 | -12.2196 | -7.1462 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.6661 | -22.0013 | -2 | 4 | 0 0 0 0 0 | -18.751 | -10.987 | -0.9935 | 2.356 | 1.2583 | -18.751 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -11.1249 | -10.2692 | -11.5229 | -11.032 | -13.325 | -11.1249 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.8 | 1.8851 | 0.5555 | -23.9168 | -5.4088 | 4 | 0 0 0 0 0 | -18.264 | -13.0121 | -2.8407 | -6.6548 | -7.1687 | -18.264 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.35 | 4.9549 | 0.9083 | -3.1815 | -14.9283 | 4 | 0 0 0 0 1 | -10.2909 | -13.1276 | -17.0236 | -1.4012 | -4.6174 | -10.2909 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.95 | 0.4 | 0.9812 | -20.7272 | -0.9942 | 4 | 0 0 0 0 0 | -16.0227 | -4.9952 | -8.1266 | -9.7286 | -14.3153 | -16.0227 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.5 | 4.9549 | 0.6409 | -9.2158 | -16.6011 | 4 | 0 0 0 0 1 | -12.7654 | -16.3342 | -16.1896 | -6.0131 | -13.084 | -12.7654 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.975 | 2.6103 | 3.4198 | -3.4748 | 1.7624 | 1.975 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.2223 | -0.1456 | -4.3339 | -1.582 | -3.6253 | -8.2223 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -7.25 | 4.9549 | 0.602 | -10.0715 | 2 | 4 | 0 0 0 0 0 | -12.6011 | 0.2325 | -14.2262 | -4.5441 | -8.7364 | -12.6011 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.5045 | 0.9809 | -24.6554 | -10.8442 | 4 | 0 0 0 0 0 | -22.2129 | -9.8702 | -10.3098 | -11.7375 | -10.6121 | -22.2129 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.8409 | -13.5514 | 2 | 4 | 0 0 0 0 0 | -11.2928 | -1.9276 | 4.6106 | 1.3336 | 4.0275 | -11.2928 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.2 | 0.5 | 0.9077 | -28.8252 | -9.4452 | 4 | 0 0 0 0 0 | -23.1876 | -10.7877 | -12.0613 | -16.7104 | -16.3414 | -23.1876 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -18.3436 | -16.2788 | -21.7212 | -19.8613 | -16.6894 | -18.3436 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.4025 | -9.518 | -0.1694 | 0.2848 | -4.8162 | -5.4025 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -23.1229 | -14.0834 | -13.5556 | -16.7644 | -18.8145 | -23.1229 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.95 | 3.2975 | 0.9426 | -35.5663 | -15.2262 | 4 | 0 0 0 0 0 | -34.2687 | -12.6885 | -18.3414 | -14.0693 | -16.4909 | -34.2687 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.7952 | -15.6253 | -4.8932 | 4 | 0 0 0 0 0 | -13.8544 | -4.3645 | -8.5252 | -3.661 | -3.9903 | -13.8544 | QC'd by Sytravon |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00368 uM | Activity at 0.092 uM | Activity at 0.460 uM | Activity at 2.300 uM | Activity at 11.50 uM | Activity at 57.50 uM | Activity at 115.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 67.4555 | 97.8288 | 42 | Partial curve; high efficacy | -4.171 | 3.5117 | 0.9924 | -94.2938 | 3.535 | -2.1 | 0 0 0 0 0 0 0 | -81.6619 | 0.072 | 1.1664 | 2.3741 | 6.9413 | 7.6375 | -31.4523 | -81.6619 | QC'd by "NCGCChem" | |
| Inhibitor | 30.1313 | 92.2227 | 80 | Complete curve; high efficacy | -4.521 | 4.9549 | 0.9994 | -95.1336 | -2.9109 | -1.1 | 0 0 0 0 0 0 0 | -95.5156 | -1.8617 | -2.9028 | -4.1558 | -3.4768 | -1.6903 | -91.5019 | -95.5156 | QC'd by "NCGCChem" | |
| Inhibitor | 0.1069 | 99.6642 | 92 | Complete curve; high efficacy | -6.971 | 1.331 | 0.9984 | -95.652 | 4.0122 | -1.1 | 0 0 0 0 0 0 0 | -98.4074 | 1.8976 | -39.6603 | -83.04 | -92.5998 | -94.5606 | -94.7465 | -98.4074 | QC'd by "NCGCChem" | |
| Inhibitor | 67.4555 | 61.0052 | 21 | Partial curve; partial efficacy | -4.171 | 2.3031 | 0.9929 | -68.3134 | -7.3082 | -2.2 | 0 0 0 0 0 0 0 | -54.7828 | -7.6473 | -6.2316 | -10.3712 | -5.2999 | -8.0837 | -32.0301 | -54.7828 | QC'd by "Asinex Ltd." | |
| Inhibitor | 21.3313 | 68.5901 | 81 | Complete curve; high efficacy | -4.671 | 2.1211 | 0.9947 | -68.9499 | -0.3598 | -1.1 | 0 0 0 0 0 0 0 | -66.6249 | 0.5009 | 1.9731 | -5.0032 | -0.0716 | -15.1281 | -62.0653 | -66.6249 | QC'd by "Asinex Ltd." | |
| Inhibitor | 11.9955 | 97.2537 | 82 | Complete curve; high efficacy | -4.921 | 1 | 0.9928 | -90.7537 | 6.5 | -1.1 | 0 0 0 0 0 0 0 | -82.2401 | 8.3929 | 7.8323 | -3.1525 | -5.664 | -43.0492 | -72.4298 | -82.2401 | QC'd by "Chem Div" | |
| Inhibitor | 75.6863 | 70.3314 | 10 | Single point of activity | -4.121 | 4.9549 | 0.9313 | -57.7333 | 12.5981 | -3 | 0 0 0 0 0 0 0 | -50.1126 | 8.8322 | 1.0776 | 17.285 | 20.8687 | 14.6925 | -1.2437 | -50.1126 | QC'd by "Chem Div" | |
| Inhibitor | 84.9214 | 55.5073 | 10 | Single point of activity | -4.071 | 4.9549 | 0.9256 | -60.6734 | -5.166 | -3 | 0 0 0 0 0 0 0 | -51.3945 | -6.356 | -4.7859 | -14.5761 | -3.4329 | -1.8424 | -6.4858 | -51.3945 | QC'd by "Specs" | |
| Inhibitor | 84.9214 | 75.4913 | 10 | Single point of activity | -4.071 | 4.9549 | 0.9733 | -81.3733 | -5.882 | -3 | 0 0 0 0 0 0 0 | -68.6444 | -12.3172 | -6.6565 | -4.1068 | -6.0028 | -6.6114 | -9.0989 | -68.6444 | QC'd by "DPISMR" | |
| Inhibitor | 60.1198 | 98.9498 | 41 | Partial curve; high efficacy | -4.221 | 3.0654 | 0.9868 | -93.5567 | 5.3931 | -2.1 | 0 0 0 0 0 0 0 | -80.7248 | 5.2796 | 1.0557 | 0.915 | 8.1967 | 11.4127 | -42.6839 | -80.7248 | QC'd by "ChemBridge" | |
| Inhibitor | 84.9214 | 57.5668 | 21 | Partial curve; partial efficacy | -4.071 | 3.6272 | 0.9655 | -65.414 | -7.8472 | -2.2 | 0 0 0 0 0 0 0 | -51.0712 | -6.8548 | -7.9942 | -14.0675 | -5.9283 | -4.3092 | -19.2492 | -51.0712 | QC'd by "DPISMR" | |
| Inhibitor | 84.9214 | 63.9988 | 10 | Single point of activity | -4.071 | 4.9549 | 0.8401 | -66.8108 | -2.812 | -3 | 0 0 0 0 0 0 0 | -55.4054 | -9.0952 | -17.8455 | 1.1947 | 3.7325 | 7.7147 | -9.1206 | -55.4054 | QC'd by "Specs" | |
| Inhibitor | 75.6863 | 61.9967 | 41 | Partial curve; high efficacy | -4.121 | 3.9295 | 0.9695 | -70.768 | -8.7713 | -2.1 | 0 0 0 0 0 0 0 | -60.4303 | -8.4281 | -5.2075 | -15.9039 | -6.072 | -8.2792 | -24.7267 | -60.4303 | QC'd by "DPISMR" | |
| Inhibitor | 42.5615 | 70.6816 | 40 | Partial curve; high efficacy | -4.371 | 1.331 | 0.9659 | -70.4712 | 0.2104 | -2.1 | 0 0 0 0 0 0 0 | -61.8168 | 1.1617 | 3.9747 | 1.2132 | -4.9171 | -13.5826 | -35.5286 | -61.8168 | QC'd by "DPISMR" | |
| Inhibitor | 75.6863 | 73.642 | 42 | Partial curve; high efficacy | -4.121 | 2.8473 | 0.9867 | -79.9088 | -6.2667 | -2.1 | 0 0 0 0 0 0 0 | -62.8097 | -6.9506 | -1.8052 | -7.0835 | -6.1403 | -10.6266 | -28.7837 | -62.8097 | QC'd by "DPISMR" | |
| Inhibitor | 95.2834 | 58.1452 | 10 | Single point of activity | -4.021 | 4.9549 | 0.8038 | -68.2179 | -10.0728 | -3 | 0 0 0 0 0 0 0 | -56.8483 | -11.814 | -27.4851 | -6.3024 | -4.4436 | -5.061 | -9.0547 | -56.8483 | QC'd by "Chem Div" | |
| Inhibitor | 84.9214 | 93.0164 | 42 | Partial curve; high efficacy | -4.071 | 3.6272 | 0.9653 | -109.3571 | -16.3407 | -2.1 | 0 0 0 0 0 0 0 | -85.9726 | -8.8577 | -18.4679 | -25.0555 | -13.1313 | -15.9635 | -34.6209 | -85.9726 | QC'd by "Chem Div" | |
| Inhibitor | 37.933 | 79.3713 | 40 | Partial curve; high efficacy | -4.421 | 1 | 0.9899 | -85.5673 | -6.196 | -2.1 | 0 0 0 0 0 0 0 | -65.5813 | -10 | -1.9435 | -8.8634 | -10.2553 | -25.0803 | -54.0159 | -65.5813 | QC'd by "ChemBridge" | |
| Inhibitor | 75.6863 | 100.3499 | 42 | Partial curve; high efficacy | -4.121 | 3.1925 | 0.9958 | -103.6557 | -3.3058 | -2.1 | 0 0 0 0 0 0 0 | -82.3149 | -4.5511 | 0.7433 | -4.49 | -3.3556 | -5.2036 | -33.6183 | -82.3149 | QC'd by "Asinex Ltd." | |
| Inhibitor | 37.933 | 55.1192 | 20 | Partial curve; partial efficacy | -4.421 | 1 | 0.9859 | -64.7054 | -9.5862 | -2.2 | 0 0 0 0 0 0 0 | -53.9212 | -7.9038 | -8.9013 | -11.5207 | -12.3012 | -24.2885 | -39.6772 | -53.9212 | QC'd by "InterBioScreen" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0009677143 uM | Activity at 0.00290 uM | Activity at 0.00871 uM | Activity at 0.026 uM | Activity at 0.078 uM | Activity at 0.235 uM | Activity at 0.705 uM | Activity at 2.116 uM | Activity at 6.349 uM | Activity at 19.05 uM | Activity at 57.14 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -4.5171 | 1.8851 | 0.8757 | -31.6659 | -6.5913 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -28.0549 | -7.5438 | -7.5899 | -3.0216 | -9.5719 | -8.1532 | -7.6821 | -5.5362 | -2.5761 | -9.6026 | -11.8662 | -28.0549 | QC'd by "NCGCChem" | ||||
| Inactive | 0 | 3.9295 | 0.8108 | -15.818 | -7.4635 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -15.6817 | -7.5387 | -9.4438 | -8.5425 | -6.6219 | -7.047 | -8.1481 | -6.9907 | -6.9753 | -4.5529 | -10.4066 | -15.6817 | QC'd by "Chemical Block" | |||||
| Inhibitor | 21.5227 | 71.8484 | 41 | Partial curve; high efficacy | -4.6671 | 2.1211 | 0.9908 | -77.8503 | -6.0019 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -72.0836 | -3.4487 | -6.5646 | -5.0067 | -5.1508 | -5.8938 | -7.7844 | -4.6185 | -7.4684 | -13.9665 | -33.9543 | -72.0836 | QC'd by "Asinex Ltd." | |
| Inhibitor | 38.2734 | 70.1721 | 10 | Single point of activity | -4.4171 | 4.095 | 0.9866 | -73.1546 | -2.9825 | -3 | 0 0 0 0 0 0 0 0 0 0 0 | -61.8596 | -1.0101 | -0.7241 | -2.294 | -1.0162 | -2.3366 | -3.5536 | -2.7991 | -3.292 | -8.3668 | -6.8273 | -61.8596 | QC'd by "Specs" | |
| Inhibitor | 15.2369 | 63.9868 | 10 | Single point of activity | -4.8171 | 2.4064 | 0.9512 | -65.2071 | -1.2203 | -3 | 0 0 0 0 0 0 0 0 0 1 0 | -62.6726 | 4.5304 | 3.3151 | -0.3081 | -4.4962 | -3.4634 | -2.1796 | -10.5843 | 1.7973 | -8.7128 | 72.1328 | -62.6726 | QC'd by "InterBioScreen" | |
| Inactive | 0 | 4.9549 | 0.4139 | -3.2792 | -0.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -2.482 | -2.2709 | -2.9043 | 1.5063 | 3.1439 | -1.5292 | -0.1484 | -2.8301 | -3.9827 | -3.2067 | -2.7445 | -2.482 | QC'd by "ChemBridge" | |||||
| Inactive | 0 | 4.5045 | 0.8845 | -19.6773 | -1 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -9.4602 | -1.9 | -2.5904 | -2.6304 | 1.4036 | -0.3195 | 2.3736 | -1.5919 | -4.3022 | -2.619 | -18.4811 | -9.4602 | QC'd by "Chem Div" | |||||
| Activator | 0 | -4.3671 | 4.9549 | 0.8877 | 133.6628 | -11.8748 | 5 | 0 0 0 0 0 0 0 0 0 0 0 | 105.6373 | -0.873 | -4.2109 | -6.0767 | -3.8685 | -5.3121 | -3.8229 | -9.5287 | -12.6612 | -36.5571 | -33.0994 | 105.6373 | QC'd by "DPISMR" | ||||
| Inactive | 0 | -4.7171 | 1.9673 | 0.963 | -31.3513 | -4.4361 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -28.6261 | -6.365 | -5.1952 | -6.9805 | -2.7223 | -1.6134 | -2.8499 | -4.6352 | -4.6185 | -7.2466 | -18.0472 | -28.6261 | QC'd by "Chem Div" | ||||
| Inactive | 0 | 1.4641 | 0.3602 | -1 | -12.9392 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -9.116 | -8.514 | -2.709 | -4.1096 | 0.9951 | 0.5099 | -0.6757 | 1.4313 | -0.516 | 1.6217 | 0.1597 | -9.116 | QC'd by "Chem Div" | |||||
| Inactive | 0 | 0.8 | 0.4171 | -2.7682 | -7.9678 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -7.3953 | -5.1982 | -8.3018 | -9.5565 | -7.0521 | -6.3351 | -3.6464 | -0.6402 | -3.7386 | -7.3031 | -2.0742 | -7.3953 | QC'd by "DPISMR" | |||||
| Inactive | 0 | 3.5117 | 0.553 | -2 | -24.7908 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -11.2719 | -17.7423 | -3.1825 | -1.0867 | -6.2985 | 1.0479 | 0.4214 | 3.0162 | 2.3176 | -2.7334 | -5.3449 | -11.2719 | QC'd by "InterBioScreen" | |||||
| Inactive | 0 | 0.8 | 0.4244 | -10.0029 | -1 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 1.1318 | -1.3083 | 1.3935 | -2.3731 | -0.0852 | -3.2798 | -3.5658 | -0.1704 | -0.6511 | -1.8742 | -6.6691 | 1.1318 | QC'd by "ChemBridge" | |||||
| Inactive | 0 | -4.5171 | 4.5045 | 0.9502 | -28.019 | -1 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -26.6825 | 2.9025 | -1.0892 | -2.8964 | -3.0729 | -0.1339 | -1.1987 | -3.4867 | -0.5781 | -0.2008 | -3.9126 | -26.6825 | QC'd by "DPISMR" | ||||
| Inhibitor | 24.1489 | 56.321 | 20 | Partial curve; partial efficacy | -4.6171 | 2.2526 | 0.9813 | -60.1737 | -3.8526 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -55.7163 | -2.9441 | -3.676 | -2.3564 | -4.2526 | -3.1825 | -2.0736 | -6.7753 | -6.8252 | -9.1983 | -21.4349 | -55.7163 | QC'd by "DPISMR" | |
| Inactive | 0 | 4 | -2.4264 | -0.5959 | -0.7494 | -4.1219 | -1.7507 | -2.9179 | -2.0087 | -3.2434 | -2.3896 | -4.257 | -2.838 | -2.4264 | QC'd by "Specs" | ||||||||||
| Inactive | 0 | 1.6266 | 0.8443 | -25.7877 | -7.1158 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -19.8231 | -6.9722 | -8.2007 | -8.1577 | -9.3372 | -4.2632 | -7.4882 | -5.8173 | -6.966 | -8.3175 | -8.5878 | -19.8231 | QC'd by "Key Organics Ltd." | |||||
| Inactive | 0 | -4.6671 | 2.8473 | 0.919 | -29.7419 | 0 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -28.1182 | 1.5634 | -0.7075 | -0.2168 | -4.5532 | -3.5433 | 0.8273 | 1.6946 | 5.4947 | -0.7589 | -12.975 | -28.1182 | QC'd by "Key Organics Ltd." | ||||
| Inactive | 0 | 4 | -0.0061 | -0.0184 | 2.0886 | -0.5406 | 1.0873 | 2.9732 | 3.1267 | 3.5874 | 5.7682 | 2.365 | -1.0689 | -0.0061 | QC'd by "ChemBridge" | ||||||||||
| Inactive | 0 | 4 | -9.5565 | -9.5104 | -11.3234 | -11.7484 | -6.4785 | -4.7219 | -2.8833 | -7.9433 | -2.7912 | -9.5821 | -5.8128 | -9.5565 | QC'd by "DPISMR" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00366 uM | Activity at 0.091 uM | Activity at 0.457 uM | Activity at 2.290 uM | Activity at 11.40 uM | Activity at 57.10 uM | Activity at 114.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 26.6795 | 92.9447 | 80 | Complete curve; high efficacy | -4.5738 | 4.9549 | 0.9928 | -89.4352 | 3.5095 | -1.1 | 0 0 0 0 0 0 0 | -85.304 | 1.3563 | 0.4301 | 2.7584 | 5.0614 | 7.7977 | -92.0115 | -85.304 | QC'd by "NCGCChem" | |
| Inhibitor | 37.6858 | 91.2122 | 80 | Complete curve; high efficacy | -4.4238 | 3.5117 | 0.9958 | -89.4323 | 1.7799 | -1.1 | 0 0 0 0 0 0 0 | -87.166 | 7.2361 | 0.3997 | -1.118 | 1.4443 | 0.1266 | -72.9053 | -87.166 | QC'd by "NCGCChem" | |
| Inhibitor | 26.6795 | 83.7396 | 40 | Partial curve; high efficacy | -4.5738 | 1.4781 | 0.993 | -76.7396 | 7 | -2.1 | 0 0 0 0 0 0 0 | -68.9497 | 7.726 | 3.728 | 5.2002 | 10.2134 | -12.2009 | -55.2489 | -68.9497 | QC'd by "NCGCChem" | |
| Inhibitor | 23.7781 | 96.0613 | 81 | Complete curve; high efficacy | -4.6238 | 4.9549 | 0.9975 | -92.5252 | 3.5361 | -1.1 | 0 0 0 0 0 0 0 | -90.0092 | 2.8265 | 1.29 | 2.3722 | 7.0012 | 1.6863 | -94.0297 | -90.0092 | QC'd by "Chemical Block" | |
| Inhibitor | 67.0158 | 74.0832 | 41 | Partial curve; high efficacy | -4.1738 | 3.132 | 0.9811 | -75.7112 | -1.628 | -2.1 | 0 0 0 0 0 0 0 | -64.1751 | 2.1049 | -3.5989 | 1.4596 | -7.9087 | -1.8347 | -29.4499 | -64.1751 | QC'd by "CGeneTech" | |
| Inhibitor | 75.193 | 69.9267 | 21 | Partial curve; partial efficacy | -4.1238 | 3.6272 | 0.9678 | -66.4779 | 3.4487 | -2.2 | 0 0 0 0 0 0 0 | -53.7712 | 5.6324 | 2.6482 | -4.781 | 5.5114 | 7.2544 | -15.2875 | -53.7712 | QC'd by "Specs" | |
| Inhibitor | 21.1923 | 89.1466 | 81 | Complete curve; high efficacy | -4.6738 | 2.4064 | 0.9986 | -89.1035 | 0.043 | -1.1 | 0 0 0 0 0 0 0 | -87.3564 | 0.0025 | 2.2132 | -1.2391 | -2.795 | -15.6425 | -82.3909 | -87.3564 | QC'd by "Specs" | |
| Inhibitor | 2.3778 | 94.0295 | 85 | Complete curve; high efficacy | -5.6238 | 4.045 | 0.9936 | -93.5118 | 0.5177 | -1.1 | 0 0 0 0 0 0 0 | -88.1264 | -1.1948 | 5.5185 | -1.9406 | -43.8184 | -98.0207 | -94.138 | -88.1264 | QC'd by "Specs" | |
| Inhibitor | 42.2841 | 62.8115 | 40 | Partial curve; high efficacy | -4.3738 | 2.0479 | 0.9771 | -66.6169 | -3.8054 | -2.1 | 0 0 0 0 0 0 0 | -61.6823 | -0.2834 | 1.3713 | -9.1692 | -6.0923 | -9.5903 | -43.8695 | -61.6823 | QC'd by "Chem Div" | |
| Inhibitor | 59.7279 | 68.7227 | 21 | Partial curve; partial efficacy | -4.2238 | 2.4064 | 0.9768 | -71.0032 | -2.2805 | -2.2 | 0 0 0 0 0 0 0 | -59.0933 | -1.7654 | 3.7117 | -8.421 | -2.332 | -3.7089 | -34.6408 | -59.0933 | QC'd by "Chem Div" | |
| Inhibitor | 75.193 | 84.511 | 42 | Partial curve; high efficacy | -4.1238 | 3.2475 | 0.9973 | -88.2822 | -3.7713 | -2.1 | 0 0 0 0 0 0 0 | -71.0471 | -3.0378 | -4.0747 | -1.515 | -4.9516 | -5.7983 | -28.3693 | -71.0471 | QC'd by "Chem Div" | |
| Inhibitor | 18.8876 | 85.6116 | 81 | Complete curve; high efficacy | -4.7238 | 1.8265 | 0.9945 | -90.9775 | -5.3659 | -1.1 | 0 0 0 0 0 0 0 | -82.9828 | -2.7169 | -5.0472 | -4.9456 | -9.4392 | -29.983 | -83.773 | -82.9828 | QC'd by "DPISMR" | |
| Inhibitor | 15.003 | 106.0106 | 82 | Complete curve; high efficacy | -4.8238 | 1.21 | 0.9958 | -103.2945 | 2.7161 | -1.1 | 0 0 0 0 0 0 0 | -92.5578 | 3.6581 | 5.2811 | -2.2215 | -8.664 | -39.3323 | -89.3643 | -92.5578 | QC'd by "InterBioScreen" | |
| Inhibitor | 37.6858 | 89.5273 | 40 | Partial curve; high efficacy | -4.4238 | 2.3031 | 0.9983 | -85.8213 | 3.706 | -2.1 | 0 0 0 0 0 0 0 | -79.4641 | 2.7124 | 6.4159 | 1.463 | 3.8993 | -1.9065 | -61.2431 | -79.4641 | QC'd by "DPISMR" | |
| Inhibitor | 75.193 | 70.0075 | 21 | Partial curve; partial efficacy | -4.1238 | 3.6272 | 0.9889 | -67.5457 | 2.4618 | -2.2 | 0 0 0 0 0 0 0 | -54.9589 | -0.2754 | 5.4224 | 1.7129 | 5.8056 | 0.4527 | -16.1846 | -54.9589 | QC'd by "DPISMR" | |
| Inhibitor | 75.193 | 76.463 | 42 | Partial curve; high efficacy | -4.1238 | 3.2475 | 0.9952 | -81.2864 | -4.8233 | -2.1 | 0 0 0 0 0 0 0 | -65.7473 | -2.4987 | -4.1607 | -5.1603 | -4.7258 | -8.0653 | -26.9253 | -65.7473 | QC'd by "DPISMR" | |
| Inhibitor | 47.4436 | 50.976 | 20 | Partial curve; partial efficacy | -4.3238 | 2.2526 | 0.9719 | -52.4178 | -1.4419 | -2.2 | 0 0 0 0 0 0 0 | -51.39 | 0.4239 | 3.0286 | -4.0535 | -3.242 | -6.1278 | -30.976 | -51.39 | QC'd by "DPISMR" | |
| Inhibitor | 42.2841 | 97.612 | 41 | Partial curve; high efficacy | -4.3738 | 3.1925 | 0.9963 | -92.085 | 5.527 | -2.1 | 0 0 0 0 0 0 0 | -90.2794 | 4.7468 | 9.1797 | 2.9301 | 3.3202 | 5.4147 | -62.7926 | -90.2794 | QC'd by "DPISMR" | |
| Inhibitor | 67.0158 | 96.0161 | 41 | Partial curve; high efficacy | -4.1738 | 3.1925 | 0.9956 | -91.7415 | 4.2746 | -2.1 | 0 0 0 0 0 0 0 | -76.6981 | 5.8402 | 3.326 | 7.8099 | 3.7545 | 0.7561 | -31.6349 | -76.6981 | QC'd by "DPISMR" | |
| Inhibitor | 59.7279 | 67.1603 | 21 | Partial curve; partial efficacy | -4.2238 | 2.7202 | 0.9905 | -66.5677 | 0.5926 | -2.2 | 0 0 0 0 0 0 0 | -55.7331 | -2.5015 | 1.7542 | -1.2605 | 0.3677 | 3.3411 | -32.3571 | -55.7331 | QC'd by "DPISMR" |
| pKi_min | pKi_max | pKd_min | pKd_max | pIC50_min | pIC50_max | pKB_min | pKB_max | Type | Action | Reference (PubMed ID) |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.9 | 9.9 | Antagonist | Antagonist | 12388666 | ||||||
| 7 | 9.3 | Agonist | Full agonist | 9605427,9760042,9824686 | ||||||
| 7.8 | 7.8 | Antagonist | Antagonist | 17220913 | ||||||
| 7.6 | 7.9 | Antagonist | Antagonist | 1353247,7908642 | ||||||
| 9.9 | 9.9 | Antagonist | Antagonist | 1353247,8819505 | ||||||
| 5.8 | 5.8 | Agonist | Agonist | 9605427 | ||||||
| 4.8 | 5.9 | Agonist | Partial agonist | 9605427 | ||||||
| 10.1 | 10.1 | Antagonist | Antagonist | 7996470 | ||||||
| 9.1 | 9.1 | Antagonist | Antagonist | 12388666 | ||||||
| 8.5 | 9.5 | Antagonist | Antagonist | 7908642,7996470,1353247 | ||||||
| 5.8 | 6.2 | Agonist | Full agonist | 9605427 | ||||||
| 9 | 9 | Antagonist | Antagonist | 7996470 | ||||||
| 5.4 | 6.2 | Agonist | Partial agonist | 9605427 | ||||||
| 5.7 | 7.6 | Agonist | Partial agonist | 9605427,9760042,9824686,9227000 | ||||||
| 7.7 | 7.7 | Antagonist | Antagonist | 15771415 | ||||||
| 9.1 | 9.1 | Antagonist | Antagonist | 7996470 | ||||||
| 7.7 | 7.7 | 6.7 | 6.7 | Antagonist | Antagonist | 10636247,15771415 | ||||
| 8 | 8 | Antagonist | Antagonist | 20404009 | ||||||
| 6.8 | 6.8 | Antagonist | Antagonist | 7996470 | ||||||
| 8.2 | 9.2 | Antagonist | Antagonist | 8819505,7908642 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0009677143 uM | Activity at 0.00290 uM | Activity at 0.00871 uM | Activity at 0.026 uM | Activity at 0.078 uM | Activity at 0.235 uM | Activity at 0.705 uM | Activity at 2.116 uM | Activity at 6.349 uM | Activity at 19.05 uM | Activity at 57.14 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 9.6138 | 100.6394 | 42 | Partial curve; high efficacy | -5.0171 | 1.331 | 0.9987 | -95.826 | 4.8134 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -87.2733 | 6.2675 | 6.0021 | 3.8785 | 6.4592 | 2.448 | 4.0849 | 2.743 | -7.6537 | -31.3965 | -66.8043 | -87.2733 | QC'd by "NCGCChem" | |
| Inhibitor | 30.4016 | 112.5664 | 40 | Partial curve; high efficacy | -4.5171 | 4.095 | 0.9923 | -108.1836 | 4.3828 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.6166 | 9.9543 | 5.132 | 3.5098 | 3.2296 | 0.9881 | 4.6601 | 5.309 | 7.4178 | 0.6341 | -12.9037 | -99.6166 | QC'd by "Chemical Block" | |
| Inhibitor | 17.0961 | 136.589 | 42 | Partial curve; high efficacy | -4.7671 | 1 | 0.9973 | -128.5627 | 8.0263 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -97.396 | 9.6212 | 5.6645 | 8.0149 | 5.5293 | 5.8843 | 8.5898 | 5.1742 | -7.5414 | -31.5015 | -63.8992 | -97.396 | QC'd by "Asinex Ltd." | |
| Inhibitor | 7.6365 | 58.3423 | 22 | Partial curve; partial efficacy | -5.1171 | 0.7 | 0.9881 | -60.3642 | -2.0219 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -49.0986 | 1.1207 | -2.3388 | -2.9235 | -5.3273 | -4.8887 | -7.8122 | -7.4062 | -20.3183 | -29.3 | -40.1007 | -49.0986 | QC'd by "Specs" | |
| Inhibitor | 19.1821 | 127.8195 | 41 | Partial curve; high efficacy | -4.7171 | 1 | 0.9861 | -122.1471 | 5.6724 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -92.5357 | 10.599 | 6.0521 | 5.54 | 2.2502 | 2.0639 | 5.8194 | 7.2626 | -11.856 | -30.4159 | -53.9417 | -92.5357 | QC'd by "InterBioScreen" | |
| Inactive | 0 | 0.7 | 0.4517 | 3.5 | 10 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 2.2191 | 6.5022 | 8.3954 | 3.1192 | 3.6158 | 4.5934 | 2.7157 | 2.4519 | 2.8554 | 6.1608 | 4.0037 | 2.2191 | QC'd by "ChemBridge" | |||||
| Inhibitor | 13.5799 | 92.6488 | 42 | Partial curve; high efficacy | -4.8671 | 1.111 | 0.9952 | -86.6704 | 5.9784 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -70.2048 | 10.2266 | 4.6865 | 6.2694 | 5.4624 | 3.7709 | 5.1055 | 1.2725 | -5.4004 | -20.1428 | -50.8845 | -70.2048 | QC'd by "Chem Div" | |
| Inhibitor | 19.1821 | 237.7599 | 43 | Partial curve; high efficacy | -4.7171 | 1 | 0.9951 | -243.2663 | -5.5064 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -186.8405 | -3.352 | -3.0571 | -7.1229 | -6.3935 | -6.9988 | -7.8057 | -17.3029 | -25.419 | -71.6325 | -115.2545 | -186.8405 | QC'd by "DPISMR" | |
| Inhibitor | 12.1031 | 98.1811 | 42 | Partial curve; high efficacy | -4.9171 | 1 | 0.9936 | -89.6811 | 8.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -71.7281 | 13.003 | 10.8725 | 8.4545 | 5.7829 | 4.4302 | 5.0051 | 2.6547 | -5.6307 | -24.3828 | -53.1958 | -71.7281 | QC'd by "Chem Div" | |
| Inhibitor | 17.0961 | 103.4274 | 41 | Partial curve; high efficacy | -4.7671 | 1.01 | 0.989 | -96.7238 | 6.7037 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -74.0331 | 11.8938 | 4.5887 | 9.6685 | 3.7753 | 4.159 | 2.0258 | 1.55 | -2.1179 | -23.4346 | -45.841 | -74.0331 | QC'd by "Chem Div" | |
| Inhibitor | 19.1821 | 109.7343 | 41 | Partial curve; high efficacy | -4.7171 | 1.1 | 0.9928 | -113.4601 | -3.7258 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -88.3645 | -0.3539 | -0.6931 | -3.967 | -7.816 | -7.816 | -4.955 | -5.8546 | -11.311 | -30.4232 | -57.3957 | -88.3645 | QC'd by "DPISMR" | |
| Inhibitor | 0.5406 | 130.8272 | 92 | Complete curve; high efficacy | -6.2671 | 1.7137 | 0.9283 | -139.723 | -8.8958 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -111.3121 | 0.1522 | -3.9398 | -4.5147 | -15.8945 | -27.3419 | -36.9462 | -83.7504 | -129.9628 | -177.7646 | -130.8928 | -111.3121 | QC'd by "InterBioScreen" | |
| Inactive | 0 | -4.6171 | 1.21 | 0.9214 | -37.9778 | -2 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -28.7315 | -2.3388 | 4.1416 | -3.0697 | -3.2808 | -2.5499 | -0.2436 | -7.0489 | -3.0047 | -7.6336 | -17.5897 | -28.7315 | QC'd by "ChemBridge" | ||||
| Inhibitor | 21.5227 | 82.2228 | 41 | Partial curve; high efficacy | -4.6671 | 2.4064 | 0.9685 | -79.1713 | 3.0514 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -77.619 | 11.3529 | 5.6359 | 1.2181 | 2.2414 | 1.1044 | -0.5847 | 5.0024 | -2.8423 | -3.3133 | -26.5551 | -77.619 | QC'd by "DPISMR" | |
| Inhibitor | 15.2369 | 127.3483 | 42 | Partial curve; high efficacy | -4.8171 | 1.1 | 0.9971 | -122.5409 | 4.8074 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.6642 | 7.2202 | 8.1671 | 4.7683 | 4.8529 | 1.7754 | 2.7224 | -1.0145 | -9.5536 | -27.9675 | -67.5854 | -98.6642 | QC'd by "DPISMR" | |
| Inhibitor | 17.0961 | 135.0168 | 42 | Partial curve; high efficacy | -4.7671 | 1 | 0.9932 | -135.5669 | -0.55 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -104.6041 | 5.4021 | 0.4911 | -0.1995 | -3.2689 | -5.8471 | -4.4199 | -3.3917 | -17.8637 | -35.4665 | -71.4088 | -104.6041 | QC'd by "Specs" | |
| Inhibitor | 24.1489 | 45.9926 | 20 | Partial curve; partial efficacy | -4.6171 | 1.5579 | 0.9749 | -56.1694 | -10.1768 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -46.8079 | -8.1645 | -12.5998 | -6.814 | -10.4512 | -12.9374 | -10.5279 | -10.9883 | -10.5126 | -17.1578 | -27.8852 | -46.8079 | QC'd by "Key Organics Ltd." | |
| Inactive | 0 | -4.6671 | 1.5386 | 0.9759 | -27.3184 | 0.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -22.7654 | 2.2036 | 0.0155 | 2.6381 | -0.45 | 0.4655 | -1.0552 | -0.031 | -0.1552 | -4.0503 | -10.9094 | -22.7654 | QC'd by "Key Organics Ltd." | ||||
| Inhibitor | 13.5799 | 115.2425 | 42 | Partial curve; high efficacy | -4.8671 | 1.111 | 0.9934 | -113.186 | 2.0565 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.3217 | 8.5021 | -1.8723 | 3.1154 | 0.399 | 1.151 | -1.0129 | -2.8699 | -8.8091 | -33.5942 | -64.8557 | -94.3217 | QC'd by "ChemBridge" | |
| Inhibitor | 7.6365 | 36.5646 | 21 | Complete curve; partial efficacy | -5.1171 | 1.7137 | 0.9819 | -40.684 | -4.1194 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -39.5222 | -0.5161 | -6.2085 | -6.1495 | -5.8251 | -5.2942 | -1.8729 | -3.613 | -7.9192 | -19.9528 | -34.4787 | -39.5222 | QC'd by "DPISMR" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0009677143 uM | Activity at 0.00290 uM | Activity at 0.00871 uM | Activity at 0.026 uM | Activity at 0.078 uM | Activity at 0.235 uM | Activity at 0.705 uM | Activity at 2.116 uM | Activity at 6.349 uM | Activity at 19.05 uM | Activity at 57.14 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 8.5683 | 103.6893 | 43 | Partial curve; high efficacy | -5.0671 | 1.21 | 0.9869 | -103.6893 | 0 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -95.4781 | 10.0273 | -3.9208 | -2.541 | -2.2404 | -3.1831 | -3.1694 | -3.8115 | -13.306 | -44.2486 | -73.4153 | -95.4781 | QC'd by "NCGCChem" | |
| Inhibitor | 30.4016 | 106.3552 | 40 | Partial curve; high efficacy | -4.5171 | 4.095 | 0.9882 | -108.4516 | -2.0964 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.8634 | 4.959 | 0.6831 | -3.3197 | 0.2732 | -3.224 | -4.9454 | -0.4918 | -3.4426 | -6.9536 | -17.1721 | -99.8634 | QC'd by "Chemical Block" | |
| Inhibitor | 6.0659 | 160.0064 | 45 | Partial curve; high efficacy | -5.2171 | 0.5 | 0.9975 | -151.305 | 8.7014 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -114.625 | 9.6803 | 5.0792 | -0.6125 | -4.2277 | -7.5739 | -15.372 | -31.0427 | -50.4033 | -71.9002 | -94.8312 | -114.625 | QC'd by "Asinex Ltd." | |
| Inhibitor | 15.2369 | 48.44 | 21 | Partial curve; partial efficacy | -4.8171 | 1 | 0.9925 | -60.157 | -11.717 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -50.1189 | -11.8312 | -12.2771 | -11.7568 | -12.3811 | -10.5975 | -12.8567 | -12.0987 | -19.7681 | -24.346 | -38.8823 | -50.1189 | QC'd by "Specs" | |
| Inhibitor | 3.4111 | 105.788 | 85 | Complete curve; high efficacy | -5.4671 | 1.21 | 0.9891 | -102.5052 | 3.2828 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -100.4953 | 8.9301 | 2.8022 | 2.2644 | -0.8916 | -0.0991 | -5.4911 | -1.302 | -38.3527 | -68.7376 | -88.1545 | -100.4953 | QC'd by "InterBioScreen" | |
| Inactive | 0 | 1 | 0.5851 | 0.547 | 8.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 2.9437 | 6.0289 | 5.8873 | 1.302 | 0.3255 | 4.2598 | -1.6275 | -0.2972 | -0.651 | 1.9389 | 1.8539 | 2.9437 | QC'd by "ChemBridge" | |||||
| Inhibitor | 13.5799 | 90.3435 | 42 | Partial curve; high efficacy | -4.8671 | 0.9 | 0.9794 | -90.3721 | -0.0286 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -71.1152 | 9.1707 | -0.2972 | -5.7034 | -0.5236 | -2.9012 | -2.7738 | -7.8545 | -14.0108 | -28.6442 | -52.6182 | -71.1152 | QC'd by "Chem Div" | |
| Inhibitor | 19.1821 | 174.5454 | 42 | Partial curve; high efficacy | -4.7171 | 1.111 | 0.997 | -188.2154 | -13.67 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -149.3773 | -10.2321 | -13.7985 | -15.3411 | -13.8126 | -13.756 | -16.0345 | -21.7804 | -22.5163 | -55.0665 | -99.3631 | -149.3773 | QC'd by "DPISMR" | |
| Inactive | 0 | 3.0654 | 0.6553 | 10 | -3.3775 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -5.4975 | 5.602 | -2.2259 | -5.0642 | -7.7084 | -8.2313 | -4.3322 | -2.5396 | 3.6749 | 14.2665 | 6.349 | -5.4975 | QC'd by "Chem Div" | |||||
| Activator | 3.8273 | 29.3128 | 0 | Complete curve; partial efficacy; poor fit | -5.4171 | 2.1876 | 0.8555 | 30.3395 | 1.0267 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 24.6059 | 11.7283 | 1.3113 | -0.3241 | -2.0922 | -0.1915 | -3.7277 | 2.1954 | 8.5015 | 20.4361 | 37.2771 | 24.6059 | QC'd by "Chem Div" | |
| Inhibitor | 7.6365 | 97.3888 | 83 | Complete curve; high efficacy | -5.1171 | 1.1341 | 0.9989 | -106.1852 | -8.7964 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.3197 | -7.2404 | -8.5383 | -8.0874 | -9.5628 | -9.9044 | -9.8907 | -16.8989 | -26.3115 | -52.1038 | -79.7541 | -98.3197 | QC'd by "DPISMR" | |
| Inhibitor | 0.9614 | 111.9643 | 88 | Complete curve; high efficacy | -6.0171 | 1 | 0.9948 | -108.7155 | 3.2487 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -104.7356 | 3.5554 | 3.1073 | 2.7637 | -0.1195 | -1.7927 | -21.9749 | -46.4296 | -67.7622 | -100.5677 | -102.1661 | -104.7356 | QC'd by "InterBioScreen" | |
| Inhibitor | 27.0955 | 54.1008 | 20 | Partial curve; partial efficacy | -4.5671 | 1.4641 | 0.962 | -61.088 | -6.9872 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -50.9067 | -1.7241 | -6.0642 | -7.1344 | -6.8074 | -7.5208 | -9.7057 | -8.0707 | -10.0624 | -15.1159 | -23.4691 | -50.9067 | QC'd by "ChemBridge" | |
| Inhibitor | 17.0961 | 123.7303 | 42 | Partial curve; high efficacy | -4.7671 | 0.9 | 0.9772 | -120.0321 | 3.6982 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.9334 | 14.7295 | 7.1492 | -0.7134 | 1.739 | -3.6266 | -1.8282 | -4.8751 | -14.7741 | -30.2021 | -58.2342 | -90.9334 | QC'd by "DPISMR" | |
| Inhibitor | 6.8061 | 110.1058 | 44 | Partial curve; high efficacy | -5.1671 | 0.8 | 0.9967 | -113.9489 | -3.8431 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.9552 | -4.5713 | -5.9755 | -4.4069 | -5.1389 | -6.3191 | -7.559 | -19.2411 | -36.9435 | -58.9483 | -77.562 | -99.9552 | QC'd by "DPISMR" | |
| Inhibitor | 8.5683 | 111.5871 | 43 | Partial curve; high efficacy | -5.0671 | 0.7 | 0.9853 | -115.1201 | -3.533 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -95.9334 | 5.0096 | -1.886 | -5.8347 | -10.7117 | -10.2549 | -11.6252 | -22.16 | -33.7262 | -50.361 | -72.8304 | -95.9334 | QC'd by "Specs" | |
| Inactive | 0 | 1.7529 | 0.6981 | -19.9259 | -13.789 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -18.727 | -13.4227 | -14.0858 | -15.2645 | -13.1575 | -13.6143 | -14.1005 | -16.5758 | -16.2811 | -24.1049 | -18.1818 | -18.727 | QC'd by "Key Organics Ltd." | |||||
| Inhibitor | 13.5799 | 75.9972 | 41 | Partial curve; high efficacy | -4.8671 | 0.9 | 0.9986 | -79.4206 | -3.4234 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -62.4399 | -4.2032 | -1.9813 | -2.4483 | -3.9343 | -4.8401 | -6.0147 | -7.9536 | -15.3552 | -29.366 | -47.6083 | -62.4399 | QC'd by "Key Organics Ltd." | |
| Inhibitor | 15.2369 | 117.2086 | 42 | Partial curve; high efficacy | -4.8171 | 0.8 | 0.9887 | -113.718 | 3.4906 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -86.15 | 8.9436 | 8.0448 | 1.1787 | -2.9026 | 1.1345 | 0.6925 | -5.9084 | -16.1485 | -37.6602 | -58.1848 | -86.15 | QC'd by "ChemBridge" | |
| Inhibitor | 5.4063 | 87.2598 | 84 | Complete curve; high efficacy | -5.2671 | 1.2876 | 0.9972 | -95.5357 | -8.276 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -93.1148 | -9.5628 | -9.7951 | -8.6066 | -7.2404 | -8.7842 | -9.3852 | -10.0956 | -29.3443 | -56.2705 | -79.4945 | -93.1148 | QC'd by "DPISMR" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00366 uM | Activity at 0.091 uM | Activity at 0.457 uM | Activity at 2.290 uM | Activity at 11.40 uM | Activity at 57.10 uM | Activity at 114.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 29.9349 | 62.4609 | 40 | Partial curve; high efficacy | -4.5238 | 1.5579 | 0.9495 | -68.4701 | -6.0092 | -2.1 | 0 0 0 0 0 0 0 | -62.4751 | -11.0143 | -12.6259 | -1.8899 | 2.6172 | -19.0747 | -50.6864 | -62.4751 | QC'd by "NCGCChem" | |
| Inhibitor | 42.2841 | 73.0444 | 40 | Partial curve; high efficacy | -4.3738 | 1.7885 | 0.9617 | -78.2246 | -5.1802 | -2.1 | 0 0 0 0 0 0 0 | -68.618 | -13.139 | -9.2027 | 3.1839 | -1.4406 | -13.047 | -51.9364 | -68.618 | QC'd by "NCGCChem" | |
| Inhibitor | 21.1923 | 63.3013 | 81 | Complete curve; high efficacy | -4.6738 | 2.7202 | 0.943 | -75.9799 | -12.6785 | -1.1 | 0 0 0 0 0 0 0 | -68.9859 | -22.7965 | -17.4913 | -6.7317 | -5.2995 | -21.5155 | -78.4911 | -68.9859 | QC'd by "NCGCChem" | |
| Inhibitor | 18.8876 | 75.537 | 81 | Complete curve; high efficacy | -4.7238 | 4.9549 | 0.9151 | -76.2745 | -0.7375 | -1.1 | 0 0 0 0 0 0 0 | -69.7166 | -2.8725 | -19.8004 | 15.176 | 4.6444 | -5.2962 | -82.1986 | -69.7166 | QC'd by "NCGCChem" | |
| Inhibitor | 16.8336 | 64.9594 | 21 | Complete curve; partial efficacy | -4.7738 | 1.8851 | 0.9153 | -54.3028 | 10.6566 | -1.2 | 0 0 0 0 0 0 0 | -51.2412 | 1.7137 | 7.0E-4 | 21.8916 | 19.2545 | -13.5169 | -46.6358 | -51.2412 | QC'd by "NCGCChem" | |
| Inhibitor | 0.6702 | 65.8643 | 86 | Complete curve; high efficacy | -6.1738 | 1.8265 | 0.9723 | -67.6601 | -1.7958 | -1.1 | 0 0 0 0 0 0 0 | -65.4483 | 4.199 | -10.0999 | -22.6315 | -64.4816 | -61.5679 | -73.7594 | -65.4483 | QC'd by "NCGCChem" | |
| Inhibitor | 67.0158 | 84.6313 | 21 | Partial curve; partial efficacy | -4.1738 | 2.0937 | 0.9825 | -72.5889 | 12.0424 | -2.2 | 0 0 0 0 0 0 0 | -54.5867 | 16.2615 | 10.597 | 13.6032 | 14.8384 | 4.0969 | -22.8714 | -54.5867 | QC'd by "Asinex Ltd." | |
| Inhibitor | 53.2326 | 61.6209 | 41 | Partial curve; high efficacy | -4.2738 | 2.7202 | 0.997 | -66.7685 | -5.1477 | -2.1 | 0 0 0 0 0 0 0 | -60.4307 | -5.4117 | -4.186 | -7.279 | -4.7061 | -4.6069 | -37.9599 | -60.4307 | QC'd by "Asinex Ltd." | |
| Inhibitor | 67.0158 | 78.8836 | 21 | Partial curve; partial efficacy | -4.1738 | 2.0937 | 0.917 | -76.2223 | 2.6614 | -2.2 | 0 0 0 0 0 0 0 | -57.403 | 15.9833 | -8.0324 | -1.0415 | 3.845 | 0 | -30.565 | -57.403 | QC'd by "ChemBridge" | |
| Inhibitor | 8.4368 | 57.2153 | 82 | Complete curve; high efficacy | -5.0738 | 2.2526 | 0.966 | -73.1626 | -15.9473 | -1.1 | 1 0 0 0 0 0 0 | -69.4773 | -37.7937 | -23.3913 | -8.4906 | -18.343 | -53.3873 | -76.0765 | -69.4773 | QC'd by "ChemBridge" | |
| Inhibitor | 47.4436 | 61.2017 | 41 | Partial curve; high efficacy | -4.3238 | 3.5117 | 0.9709 | -70.7447 | -9.543 | -2.1 | 0 0 0 0 0 0 0 | -73.6924 | -13.9659 | -9.6268 | -11.1324 | -12.0237 | -2.4307 | -47.9332 | -73.6924 | QC'd by "DPISMR" | |
| Inhibitor | 18.8876 | 74.1239 | 81 | Complete curve; high efficacy | -4.7238 | 3.132 | 0.9688 | -83.819 | -9.6952 | -1.1 | 0 0 0 0 0 0 0 | -74.9957 | -4.658 | -15.7696 | -10.2628 | -10.4954 | -18.9827 | -90.7132 | -74.9957 | QC'd by "DPISMR" | |
| Inhibitor | 53.2326 | 68.6064 | 41 | Partial curve; high efficacy | -4.2738 | 3.0654 | 0.9964 | -65.6401 | 2.9663 | -2.1 | 0 0 0 0 0 0 0 | -60.3334 | 0.331 | 2.4373 | 5.004 | 3.485 | 3.4846 | -34.1094 | -60.3334 | QC'd by "InterBioScreen" | |
| Inhibitor | 33.5875 | 88.3402 | 40 | Partial curve; high efficacy | -4.4738 | 1.4781 | 0.9941 | -72.2292 | 16.1111 | -2.1 | 0 0 0 0 0 0 0 | -63.5706 | 14.5988 | 14.5702 | 17.5402 | 17.4262 | -0.136 | -41.9943 | -63.5706 | QC'd by "Enamine" | |
| Inhibitor | 23.7781 | 71.6787 | 80 | Complete curve; high efficacy | -4.6238 | 2.3332 | 0.9944 | -74.4223 | -2.7435 | -1.1 | 0 0 0 0 0 0 0 | -72.4352 | 0 | -0.7365 | -5.1511 | -7.0135 | -12.9029 | -66.5745 | -72.4352 | QC'd by "DPISMR" | |
| Inhibitor | 59.7279 | 73.9456 | 41 | Partial curve; high efficacy | -4.2238 | 2.4729 | 0.9779 | -73.3593 | 0.5863 | -2.1 | 0 0 0 0 0 0 0 | -60.8782 | 8.2586 | 0.1909 | -3.514 | -1.9976 | 0 | -34.2469 | -60.8782 | QC'd by "ChemBridge" | |
| Inhibitor | 0.9466 | 110.3371 | 87 | Complete curve; high efficacy | -6.0238 | 4.9549 | 0.9786 | -91.6225 | 18.7145 | -1.1 | 0 0 0 0 0 0 0 | -75.6602 | 13.6738 | 19.6505 | 20.7421 | -98.862 | -99.9968 | -91.5058 | -75.6602 | QC'd by "Chem Div" | |
| Inhibitor | 84.3679 | 77.4288 | 42 | Partial curve; high efficacy | -4.0738 | 3.5722 | 0.9583 | -85.3871 | -7.9583 | -2.1 | 0 0 0 0 0 0 0 | -65.4447 | -5.6268 | -2.1943 | -4.616 | -13.272 | -14.5325 | -24.0145 | -65.4447 | QC'd by "InterBioScreen" | |
| Inhibitor | 59.7279 | 86.8514 | 41 | Partial curve; high efficacy | -4.2238 | 2.2481 | 0.9965 | -79.4437 | 7.4077 | -2.1 | 0 0 0 0 0 0 0 | -62.4573 | 9.1772 | 9.3888 | 6.5075 | 4.5989 | 6.1067 | -34.4838 | -62.4573 | QC'd by "InterBioScreen" | |
| Inhibitor | 6.7016 | 72.7452 | 83 | Complete curve; high efficacy | -5.1738 | 2.1211 | 0.9838 | -76.0235 | -3.2783 | -1.1 | 0 0 0 0 0 0 0 | -69.6223 | -8.0023 | 1.7429 | -3.4087 | -11.3168 | -58.632 | -81.0403 | -69.6223 | QC'd by "Life Chemicals" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000000311 uM | Activity at 0.0000000880 uM | Activity at 0.0000001756 uM | Activity at 0.0000004972 uM | Activity at 0.0000014063 uM | Activity at 0.0000028127 uM | Activity at 0.0000079555 uM | Activity at 0.0000225014 uM | Activity at 0.0000450029 uM | Activity at 0.0001299230 uM | Activity at 0.0003002708 uM | Activity at 0.0008965874 uM | Activity at 0.00268 uM | Activity at 0.00700 uM | Activity at 0.016 uM | Activity at 0.032 uM | Activity at 0.076 uM | Activity at 0.219 uM | Activity at 0.631 uM | Activity at 1.728 uM | Activity at 3.886 uM | Activity at 8.589 uM | Activity at 17.80 uM | Activity at 49.20 uM | Activity at 107.3 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.9549 | 0.4153 | -14.5146 | 1 | 4 | 0 0 0 0 1 | 4.685 | -8.5335 | 0.7807 | 11.3474 | -12.5122 | 4.685 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 12.5893 | 29.2705 | 0 | Single point of activity | -4.9 | 4.9549 | 0.9612 | 31 | 1.7295 | 3 | 0 0 0 0 0 | 30.9001 | -1.4754 | 1.0166 | 5.6243 | 6.6083 | 30.9001 | QC'd by "Microsource" | ||||||||||||||||||||||
| Activator | 8.9125 | 65.9699 | 0 | Partial curve; partial efficacy | -5.05 | 0.6 | 0.9478 | 60.7629 | -5.207 | 2.2 | 0 0 0 0 0 | 46.0767 | -2.3225 | 0.7459 | 18.7564 | 22.5194 | 46.0767 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.3508 | -5.4241 | 12 | 4 | 0 0 0 0 0 | 2.824 | 6.9985 | -6.3081 | -17.4367 | -1.0266 | 2.824 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.095 | 0.8518 | -20.6942 | -4.8432 | 4 | 1 0 0 0 0 | -16.9639 | -25.916 | -5.286 | -19.6983 | -24.7451 | -16.9639 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8518 | -16.2964 | 1.5 | 4 | 0 0 0 0 1 | 4.1206 | 1.8961 | -0.6171 | -21.497 | -11.4248 | 4.1206 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 2.2387 | 83.6659 | 0 | Partial curve; partial efficacy; poor fit | -5.65 | 0.5 | 0.8806 | 54.0974 | -29.5685 | 2.4 | 0 0 0 0 0 | 44.3794 | -19.3312 | -4.1329 | 18.8496 | 13.5792 | 44.3794 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 12.5893 | 81.1747 | 42 | Partial curve; high efficacy | -4.9 | 4.095 | 0.9407 | -88.2352 | -7.0605 | -2.1 | 0 0 0 0 0 | -88.059 | -2.1141 | 2.5457 | -21.0606 | -24.383 | -88.059 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.9754 | 0.5 | 18 | 4 | 0 0 0 0 0 | 0.1686 | 15.5939 | 9.5523 | 5.2389 | 3.3969 | 0.1686 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.516 | 14 | -11.1922 | 4 | 0 0 0 0 0 | 8.9233 | 2.0681 | -9.5798 | -21.4101 | -15.067 | 8.9233 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inhibitor | 10 | 111.4578 | 10 | Partial curve; high efficacy; poor fit | -5 | 4.095 | 0.8557 | -88.0204 | 23.4373 | -2.3 | 0 0 0 0 0 | -86.963 | 0.1371 | 16.1149 | 55.0816 | -24.8092 | -86.963 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 12.5893 | 111.8609 | 10 | Single point of activity | -4.9 | 1.3987 | 0.9539 | -66.6934 | 45.1675 | -3 | 0 0 0 0 0 | -51.9056 | 34.8895 | 58.2591 | 32.624 | 3.3045 | -51.9056 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4 | 9.4501 | 23.4721 | 50.1914 | -0.8776 | 27.4967 | 9.4501 | QC'd by "Microsource" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 3.6272 | 0.9908 | -9.6077 | 22.5 | 4 | 0 0 0 0 0 | -9.2564 | 21.9907 | 20.6042 | 24.2232 | 8.6092 | -9.2564 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 0 | Single point of activity | 4.9549 | 0.3547 | 25.2512 | 5 | 3 | 0 0 0 0 1 | 15.4142 | 5.7176 | 6.5342 | 43.2316 | 7.0919 | 15.4142 | QC'd by "Microsource" | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6074 | 7 | 18.5 | 4 | 0 0 0 0 0 | 11.6515 | 12.5897 | 21.5938 | 21.2209 | 4.3118 | 11.6515 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 2.2387 | 52.7895 | 0 | Partial curve; partial efficacy | -5.65 | 2.2526 | 0.9613 | 44.2358 | -8.5537 | 2.2 | 0 0 0 0 1 | -9.4264 | -2.4981 | -13.182 | 11.9591 | 42.1127 | -9.4264 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.942 | 28 | 1.1909 | 4 | 0 0 0 0 1 | 1.5316 | 4.6729 | 1.2372 | -2.341 | 24.4478 | 1.5316 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inhibitor | 35.4813 | 55.7622 | 10 | Single point of activity | -4.45 | 4.9549 | 0.7876 | -42.7915 | 12.9707 | -3 | 0 0 0 0 0 | -30.6839 | 14.5151 | 3.8713 | 4.7738 | 29.0235 | -30.6839 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 35.4813 | 49.2317 | 10 | Single point of activity | -4.45 | 4.4495 | 0.7066 | -51.9324 | -2.7008 | -3 | 0 0 0 0 0 | -40.193 | -17.9891 | 11.8148 | -5.5992 | 0.7455 | -40.193 | QC'd by "Microsource" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000000311 uM | Activity at 0.0000000880 uM | Activity at 0.0000001756 uM | Activity at 0.0000004972 uM | Activity at 0.0000014063 uM | Activity at 0.0000028127 uM | Activity at 0.0000079555 uM | Activity at 0.0000225014 uM | Activity at 0.0000450029 uM | Activity at 0.0001299230 uM | Activity at 0.0003002708 uM | Activity at 0.0008965874 uM | Activity at 0.00268 uM | Activity at 0.00700 uM | Activity at 0.016 uM | Activity at 0.032 uM | Activity at 0.076 uM | Activity at 0.219 uM | Activity at 0.631 uM | Activity at 1.728 uM | Activity at 3.886 uM | Activity at 8.587 uM | Activity at 17.80 uM | Activity at 49.20 uM | Activity at 107.3 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 25.1189 | 46.3945 | 20 | Partial curve; partial efficacy | -4.6 | 2.2526 | 0.9287 | -51.2557 | -4.8612 | -2.2 | 0 0 0 0 0 | -41.1028 | -5.7868 | -8.9838 | -1.9677 | -26.4188 | -41.1028 | QC'd by "BIOMOL" | ||||||||||||||||||||||
| Inactive | 0 | 3.5117 | 0.9435 | 10 | -4.567 | 4 | 0 0 0 0 1 | -5.6299 | -3.6518 | -3.5753 | -4.2225 | 6.795 | -5.6299 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.9376 | 11 | -2.7695 | 4 | 0 0 0 0 1 | -2.8045 | -1.4193 | -3.1412 | -1.9048 | 7.584 | -2.8045 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7625 | 1 | -16.7 | 4 | 0 0 0 0 | -0.288 | -12.25 | 5.019 | -2.495 | -0.288 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8335 | 4.5 | -7.0946 | 4 | 0 0 0 0 | 3.0138 | -4.2455 | 6.6652 | 3.4342 | 3.0138 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.993 | 0.5 | -16.2895 | 4 | 0 0 0 0 1 | -17.2531 | -11.9079 | 0.4577 | 0.7459 | 0.1472 | -17.2531 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.989 | -13.9862 | -8.1964 | 4 | 0 0 0 0 | -13.7385 | -8.6044 | -8.0804 | -9.4725 | -13.7385 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8435 | -11.2843 | 4 | 4 | 0 0 0 0 0 | -11.9036 | 3.4878 | 5.2393 | 0.5291 | 5.9839 | -11.9036 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.7241 | 0.6 | -14.6999 | 4 | 0 0 0 0 1 | -12.1307 | -11.4165 | -6.1179 | -8.0206 | -2.8333 | -12.1307 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8652 | 1 | -19.7041 | 4 | 0 0 0 0 0 | -4.2947 | -18.0867 | -15.9371 | 4.8395 | 2.1157 | -4.2947 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inhibitor | 14.1254 | 42.1465 | 10 | Single point of activity | -4.85 | 4.9549 | 0.8997 | -40.1465 | 2 | -3 | 0 0 0 0 0 | -41.8192 | -2.393 | 5.1804 | -2.5248 | 4.6867 | -41.8192 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6566 | -10.2454 | 0 | 4 | 0 0 0 0 0 | -10.2045 | -4.5492 | -0.0989 | 4.6103 | -5.6017 | -10.2045 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5279 | 3 | -11.3522 | 4 | 0 0 0 0 | 1.078 | -15.7102 | -2.9932 | -14.9547 | 1.078 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 1.6924 | 0.9123 | 0.5 | -10.147 | 4 | 0 0 0 0 | 0.4297 | -9.2892 | -3.9336 | -3.1566 | 0.4297 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 2.4064 | 0.7886 | 8 | -4.3029 | 4 | 0 0 0 0 0 | 5.7256 | -1.9822 | -4.4191 | -3.8175 | 8.0142 | 5.7256 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.997 | 5.5 | -12.076 | 4 | 0 0 0 1 | -6.5693 | -12.5633 | -7.4947 | 4.9219 | -6.5693 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9232 | -18.4489 | -2.2837 | 4 | 0 0 0 0 | -16.2075 | -1.3456 | -4.9534 | -0.2364 | -16.2075 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9481 | 2 | -17.5643 | 4 | 0 0 0 0 1 | -13.5121 | -12.9703 | 3.6247 | 1.4507 | 0.7522 | -13.5121 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5725 | -10.2193 | 7.5 | 4 | 0 0 0 0 0 | -12.7555 | 5.891 | 7.5423 | -18.5161 | 0.6587 | -12.7555 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inhibitor | 31.6228 | 100.7069 | 40 | Partial curve; high efficacy | -4.5 | 3.5722 | 0.9933 | -104.0783 | -3.3715 | -2.1 | 0 0 0 0 0 | -83.3961 | 0.3188 | -7.6251 | -4.9588 | -20.5702 | -83.3961 | QC'd by "BIOMOL" |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.03698 | Ki | = | 36.98 | nM |
| 0.008492 | Ki | = | 8.492 | nM |
| 0.38994 | Ki | = | 389.94 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 0.2485 | EC50 | = | 248.5 | nM | |
| 0.0688 | EC50 | = | 68.8 | nM | |
| 0.0744 | EC50 | = | 74.4 | nM | |
| 0.2605 | EC50 | = | 260.5 | nM | |
| 0.364 | EC50 | = | 364 | nM | |
| 0.342 | EC50 | = | 342 | nM | |
| 0.441 | EC50 | = | 441 | nM | |
| 0.652 | EC50 | = | 652 | nM | |
| 0.0977 | EC50 | = | 97.7 | nM | |
| 0.2631 | EC50 | = | 263.1 | nM | |
| 0.352 | EC50 | = | 352 | nM | |
| 0.01413 | EC50 | = | 14.13 | nM | |
| 1.099 | EC50 | = | 1099 | nM | |
| 0.2072 | EC50 | = | 207.2 | nM | |
| 0.0825 | EC50 | = | 82.5 | nM | |
| 0.0404 | EC50 | = | 40.4 | nM | |
| 0.0831 | EC50 | = | 83.1 | nM | |
| 0.7 | EC50 | = | 700 | nM | |
| 0.1714 | EC50 | = | 171.4 | nM | |
| 0.1067 | EC50 | = | 106.7 | nM |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| IFI | = | 12.4 | % | |
| IFI | = | 0 | % | |
| IFI | = | 4.118 | % | |
| IFI | = | 6.952 | % | |
| IFI | = | 2.614 | % | |
| IFI | = | 1.163 | % | |
| IFI | = | 6.061 | % | |
| IFI | = | 1.84 | % | |
| IFI | = | 1.613 | % | |
| IFI | = | 0 | % | |
| IFI | = | 22.64 | % | |
| IFI | = | 1.075 | % | |
| IFI | = | 0 | % | |
| IFI | = | 14.16 | % | |
| IFI | = | 0 | % | |
| IFI | = | 0.7812 | % | |
| IFI | = | 3.937 | % | |
| IFI | = | 3.876 | % | |
| IFI | = | 7.092 | % | |
| IFI | = | 0.5495 | % |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 0.01422 | EC50 | = | 14.22 | nM | |
| 0.0687 | EC50 | = | 68.7 | nM | |
| 0.0837 | EC50 | = | 83.7 | nM | |
| 0.46 | EC50 | = | 460 | nM | |
| 0.442 | EC50 | = | 442 | nM | |
| 0.766 | EC50 | = | 766 | nM | |
| 1.655 | EC50 | = | 1655 | nM | |
| 0.1708 | EC50 | = | 170.8 | nM | |
| 0.958 | EC50 | = | 958 | nM | |
| 0.338 | EC50 | = | 338 | nM | |
| 0.3142 | EC50 | = | 314.2 | nM | |
| 0.627 | EC50 | = | 627 | nM | |
| 0.0841 | EC50 | = | 84.1 | nM | |
| 0.711 | EC50 | = | 711 | nM | |
| 0.2319 | EC50 | = | 231.9 | nM | |
| 0.547 | EC50 | = | 547 | nM | |
| 0.366 | EC50 | = | 366 | nM | |
| 0.1165 | EC50 | = | 116.5 | nM | |
| 1.25 | EC50 | > | 1250 | nM | |
| 1.601 | EC50 | = | 1601 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 19.61 | CC50 | = | 19610 | nM | |
| 6.25 | CC50 | > | 6250 | nM | |
| 12.42 | CC50 | = | 12420 | nM | |
| 20.22 | CC50 | = | 20220 | nM | |
| 100 | CC50 | > | 100000 | nM | |
| 100 | CC50 | > | 100000 | nM | |
| 8.94 | CC50 | = | 8940 | nM | |
| 1.587 | CC50 | = | 1587 | nM | |
| 100 | CC50 | > | 100000 | nM | |
| 25.8 | CC50 | = | 25800 | nM | |
| 0.835 | CC50 | = | 835 | nM | |
| 100 | CC50 | > | 100000 | nM | |
| 100 | CC50 | > | 100000 | nM | |
| 10 | CC50 | > | 10000 | nM | |
| 100 | CC50 | > | 100000 | nM | |
| 93.22 | CC50 | > | 93220 | nM | |
| 13.11 | CC50 | = | 13110 | nM | |
| 28.86 | CC50 | = | 28860 | nM | |
| CC50 | Not Determined | ||||
| 37.19 | CC50 | = | 37190 | nM |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Log 1/LD10 | = | 4.74 |
| Log 1/LD10 | = | 4.02 |
| Log 1/LD10 | = | 5.26 |
| Log 1/LD10 | = | 3.78 |
| Log 1/LD10 | = | 4.55 |
| Log 1/LD10 | < | 3 |
| Log 1/LD10 | = | 4.16 |
| Log 1/LD10 | < | 3 |
| Log 1/LD10 | = | 3.37 |
| Log 1/LD10 | = | 4.2 |
| Log 1/LD10 | = | 3.44 |
| Log 1/LD10 | = | 3.71 |
| Log 1/LD10 | = | 3.55 |
| Log 1/LD10 | = | 3.31 |
| Log 1/LD10 | = | 4.68 |
| Log 1/LD10 | = | 4.77 |
| Log 1/LD10 | = | 4.52 |
| Log 1/LD10 | = | 4.59 |
| Log 1/LD10 | = | 3.17 |
| Log 1/LD10 | = | 3.75 |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Dose-Dependent Effect |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Dose-Dependent Effect |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Dose-Dependent Effect |
| Standard Type | Activity Comment |
|---|---|
| Activity | Dose-Dependent Effect |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Active |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Active |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Active |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Dose-Dependent Effect |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Dose-Dependent Effect |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 0.6 | IC50 | = | 600 | nM | |
| 8.23 | IC50 | = | 8230 | nM | |
| 1.05 | IC50 | = | 1050 | nM | |
| IC50 | Not Determined | ||||
| IC50 | Not Determined | ||||
| 1.16 | IC50 | = | 1160 | nM | |
| 3.62 | IC50 | = | 3620 | nM | |
| 0.073 | IC50 | = | 73 | nM | |
| 0.22 | IC50 | = | 220 | nM | |
| 0.11 | IC50 | = | 110 | nM | |
| 0.97 | IC50 | = | 970 | nM | |
| 1.66 | IC50 | = | 1660 | nM | |
| 0.71 | IC50 | = | 710 | nM | |
| 0.28 | IC50 | = | 280 | nM | |
| 0.23 | IC50 | = | 230 | nM |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 100 | % |
| Inhibition | = | 100 | % |
| Inhibition | = | 67.84 | % |
| Inhibition | = | 100 | % |
| Inhibition | = | 100 | % |
| Inhibition | = | 99.17 | % |
| Inhibition | = | 29.81 | % |
| Inhibition | = | 4.01 | % |
| Inhibition | = | 100 | % |
| Inhibition | = | 57.92 | % |
| Inhibition | = | 100 | % |
| Inhibition | = | 100 | % |
| Inhibition | = | 95.34 | % |
| Inhibition | = | 100 | % |
| Inhibition | = | 22.41 | % |
| mP_A | FluorTotal_A | Pchan_A | Schan_A | mP_B | FluorTotal_B | Pchan_B | Schan_B | Z-score_A | Z-score_B | Percent Ctrl_A | Percent Ctrl_B | STD_A | STD_B | Note: Polarization Artifact |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122.4 | 19579888 | 6065842 | 7448204 | 128.1 | 19637672 | 6057220 | 7523232 | -1.18225 | -0.635232 | 93.2647 | 101.541 | -1.8003 | 0.362745 | |
| 124.6 | 19582526 | 6056571 | 7469384 | 129.8 | 19625175 | 6045019 | 7535137 | -0.634716 | -0.199611 | 97.3807 | 104.669 | -0.700117 | 1.09906 | |
| 124.2 | 19663896 | 6083826 | 7496244 | 126.2 | 19699034 | 6084886 | 7529262 | -0.734268 | -1.1221 | 96.6324 | 98.0451 | -0.90015 | -0.460198 | |
| 123 | 19731798 | 6110340 | 7511118 | 126.7 | 19714113 | 6087353 | 7539407 | -1.03292 | -0.993979 | 94.3873 | 98.965 | -1.50025 | -0.243634 | |
| 128.1 | 19896360 | 6137066 | 7622228 | 130.5 | 19724618 | 6072617 | 7579384 | 0.236366 | -0.0202377 | 103.929 | 105.957 | 1.05018 | 1.40225 | |
| 125.6 | 19867716 | 6140208 | 7587300 | 131.3 | 19673493 | 6053122 | 7567249 | -0.385835 | 0.18476 | 99.2516 | 107.429 | -0.200033 | 1.74875 | |
| 127.7 | 20023968 | 6178251 | 7667466 | 128.8 | 19866494 | 6124246 | 7618002 | 0.136814 | -0.455859 | 103.181 | 102.829 | 0.850142 | 0.665934 | |
| 129.2 | 19617723 | 6045630 | 7526463 | 132.7 | 19789155 | 6081720 | 7625715 | 0.510134 | 0.543507 | 105.987 | 110.005 | 1.60027 | 2.35513 | |
| 130.9 | 19747075 | 6077508 | 7592059 | 133.8 | 19696771 | 6048221 | 7600329 | 0.933231 | 0.82538 | 109.167 | 112.029 | 2.45041 | 2.83157 | |
| 127.4 | 19957146 | 6158996 | 7639154 | 131.1 | 19907155 | 6125922 | 7655311 | 0.0621494 | 0.133511 | 102.619 | 107.061 | 0.700117 | 1.66213 | |
| 128.6 | 19704360 | 6075475 | 7553410 | 127.9 | 19896451 | 6137996 | 7620459 | 0.360806 | -0.686482 | 104.864 | 101.173 | 1.30022 | 0.276119 | |
| 126.5 | 19754661 | 6100993 | 7552675 | 131.2 | 19811438 | 6095996 | 7619446 | -0.161843 | 0.159136 | 100.935 | 107.245 | 0.250042 | 1.70544 | |
| 125.2 | 19898037 | 6151330 | 7595377 | 128.5 | 19820522 | 6111613 | 7597296 | -0.485388 | -0.532733 | 98.5033 | 102.277 | -0.400067 | 0.535996 | |
| 125.2 | 19744447 | 6103923 | 7536601 | 130.1 | 19613194 | 6040039 | 7533116 | -0.485388 | -0.122737 | 98.5033 | 105.221 | -0.400067 | 1.229 | |
| 127.4 | 19962800 | 6160970 | 7640860 | 131.3 | 19894559 | 6121179 | 7652201 | 0.0621494 | 0.18476 | 102.619 | 107.429 | 0.700117 | 1.74875 | |
| 128.8 | 20020402 | 6171580 | 7677242 | 132.5 | 19888130 | 6113399 | 7661332 | 0.410582 | 0.492258 | 105.239 | 109.637 | 1.40023 | 2.26851 | |
| 128.3 | 19971225 | 6158905 | 7653415 | 131.8 | 20071564 | 6173303 | 7724958 | 0.286142 | 0.312884 | 104.303 | 108.349 | 1.15019 | 1.96532 | |
| 128.7 | 19749821 | 6088940 | 7571941 | 129 | 19670633 | 6062787 | 7545059 | 0.385694 | -0.404609 | 105.051 | 103.197 | 1.35023 | 0.752559 | |
| 125.7 | 19727542 | 6096177 | 7535188 | 129 | 19624155 | 6048706 | 7526743 | -0.360947 | -0.404609 | 99.4387 | 103.197 | -0.150025 | 0.752559 | |
| 127.8 | 20049952 | 6185948 | 7678056 | 130.8 | 20021937 | 6162516 | 7696905 | 0.161702 | 0.0566366 | 103.368 | 106.509 | 0.90015 | 1.53219 |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| Inhibition | = | 15 | % | |
| Inhibition | = | 20 | % | |
| Inhibition | = | 1 | % | |
| Inhibition | = | 0 | % | |
| Inhibition | = | 18 | % | |
| Inhibition | = | 24 | % | |
| Inhibition | = | 5 | % | |
| Inhibition | = | -9 | % | |
| Inhibition | = | -3 | % | |
| Inhibition | = | 1 | % | |
| Inhibition | = | 14 | % | |
| Inhibition | = | -5 | % | |
| Inhibition | = | 9 | % | |
| Inhibition | = | -2 | % | |
| Inhibition | = | 5 | % | |
| Inhibition | = | -4 | % | |
| Inhibition | = | 24 | % | |
| Inhibition | = | 105 | % | |
| Inhibition | = | -12 | % | Outside typical range |
| Inhibition | = | -2 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment | Data Validity Comment |
|---|---|---|---|---|---|
| Inhibition | = | 19 | % | Inactive | |
| Inhibition | = | 105 | % | Highly active | |
| Inhibition | = | 6 | % | Inactive | |
| Inhibition | = | 26 | % | Weakly active | |
| Inhibition | = | 11 | % | Inactive | |
| Inhibition | = | 3 | % | Inactive | |
| Inhibition | = | 1 | % | Inactive | |
| Inhibition | = | 69 | % | Active | |
| Inhibition | = | 83 | % | Active | |
| Inhibition | = | 13 | % | Inactive | |
| Inhibition | = | 16 | % | Inactive | |
| Inhibition | = | 7 | % | Inactive | |
| Inhibition | = | 3 | % | Inactive | |
| Inhibition | = | 6 | % | Inactive | |
| Inhibition | = | 38 | % | Weakly active | |
| Inhibition | = | 60 | % | Active | |
| Inhibition | = | 95 | % | Active | |
| Inhibition | = | 26 | % | Weakly active | |
| Inhibition | = | 23 | % | Inactive | |
| Inhibition | = | 83 | % | Active |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment | Data Validity Comment |
|---|---|---|---|---|---|
| Inhibition | = | 9900 | % | >50 | Outside typical range |
| Inhibition | = | 500 | % | Outside typical range | |
| Inhibition | = | 8100 | % | >50 | Outside typical range |
| Inhibition | = | 1400 | % | Outside typical range | |
| Inhibition | = | -3900 | % | Outside typical range | |
| Inhibition | = | -2400 | % | Outside typical range | |
| Inhibition | = | 100 | % | ||
| Inhibition | = | 5700 | % | >50 | Outside typical range |
| Inhibition | = | -2900 | % | Outside typical range | |
| Inhibition | = | -1300 | % | Outside typical range | |
| Inhibition | = | 6500 | % | >50 | Outside typical range |
| Inhibition | = | 900 | % | Outside typical range | |
| Inhibition | = | -1700 | % | Outside typical range | |
| Inhibition | = | -3100 | % | Outside typical range | |
| Inhibition | = | 2800 | % | Outside typical range | |
| Inhibition | = | 9600 | % | >50 | Outside typical range |
| Inhibition | = | 200 | % | Outside typical range | |
| Inhibition | = | -6700 | % | Outside typical range | |
| Inhibition | = | -9600 | % | Outside typical range | |
| Inhibition | = | -2600 | % | Outside typical range |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment | Data Validity Comment |
|---|---|---|---|---|---|
| Inhibition | = | 7700 | % | >50 | Outside typical range |
| Inhibition | = | -2000 | % | Outside typical range | |
| Inhibition | = | 5100 | % | >50 | Outside typical range |
| Inhibition | = | -6900 | % | Outside typical range | |
| Inhibition | = | -300 | % | Outside typical range | |
| Inhibition | = | -6100 | % | Outside typical range | |
| Inhibition | = | -4200 | % | Outside typical range | |
| Inhibition | = | -1000 | % | Outside typical range | |
| Inhibition | = | -8200 | % | Outside typical range | |
| Inhibition | = | -1300 | % | Outside typical range | |
| Inhibition | = | 8100 | % | >50 | Outside typical range |
| Inhibition | = | 3000 | % | Outside typical range | |
| Inhibition | = | -6500 | % | Outside typical range | |
| Inhibition | = | -8600 | % | Outside typical range | |
| Inhibition | = | -6100 | % | Outside typical range | |
| Inhibition | = | 7300 | % | >50 | Outside typical range |
| Inhibition | = | -28700 | % | Outside typical range | |
| Inhibition | = | -11500 | % | Outside typical range | |
| Inhibition | = | -16700 | % | Outside typical range | |
| Inhibition | = | -14100 | % | Outside typical range |